126 related articles for article (PubMed ID: 21856202)
21. The prevalence of HPV associated cervical intraepithelial neoplasia in women under age 21: who will be missed under the new cervical cancer screening guidelines?
DeCew AE; Hadler JL; Daley AM; Niccolai L
J Pediatr Adolesc Gynecol; 2013 Dec; 26(6):346-9. PubMed ID: 24119656
[TBL] [Abstract][Full Text] [Related]
22. Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.
Zhao FH; Zhu FC; Chen W; Li J; Hu YM; Hong Y; Zhang YJ; Pan QJ; Zhu JH; Zhang X; Chen Y; Tang H; Zhang H; Durand C; Datta SK; Struyf F; Bi D;
Int J Cancer; 2014 Dec; 135(11):2604-11. PubMed ID: 24740547
[TBL] [Abstract][Full Text] [Related]
23. Characterization of HPV subtypes not covered by the nine-valent vaccine in patients with CIN 2-3 and cervical squamous cell carcinoma.
Ma MJ; Wang YN; Zhu JF; Wang XY; Jin YB; Liu XN; Wu SF; Yang YB
Curr Probl Cancer; 2021 Dec; 45(6):100761. PubMed ID: 34154817
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
Aleksioska-Papestiev I; Chibisheva V; Micevska M; Dimitrov G
Med Arch; 2018 Feb; 72(1):26-30. PubMed ID: 29416214
[TBL] [Abstract][Full Text] [Related]
25. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
[TBL] [Abstract][Full Text] [Related]
26. Candidate HPV genotypes not included in the 9-valent vaccine for prevention of CIN 2-3.
Gonzalez-Bosquet E; Gibert M; Serra M; Hernandez-Saborit A; Gonzalez-Fernandez A
Int J Gynecol Cancer; 2020 Jul; 30(7):954-958. PubMed ID: 32467333
[TBL] [Abstract][Full Text] [Related]
27. [Human papillomavirus infection and cervical intraepithelial neoplasia in dialyzed patients].
David P; Tarrano E; De Mauri A; Navino C; Brustia M; Chiarinotti D; Gherzi R; De Leo M
G Ital Nefrol; 2012; 29(2):205-9. PubMed ID: 22538949
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus and predictors of cervical intraepithelial neoplasia among young mothers in a prospective follow-up study.
Louvanto K; Syrjänen KJ; Rintala MA; Grénman SE; Syrjänen SM
Acta Obstet Gynecol Scand; 2011 Feb; 90(2):167-73. PubMed ID: 21241262
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.
Rodríguez AC; Schiffman M; Herrero R; Hildesheim A; Bratti C; Sherman ME; Solomon D; Guillén D; Alfaro M; Morales J; Hutchinson M; Katki H; Cheung L; Wacholder S; Burk RD
J Natl Cancer Inst; 2010 Mar; 102(5):315-24. PubMed ID: 20157096
[TBL] [Abstract][Full Text] [Related]
30. Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance.
Insinga RP; Perez G; Wheeler CM; Koutsky LA; Garland SM; Leodolter S; Joura EA; Ferris DG; Steben M; Hernandez-Avila M; Brown DR; Elbasha E; Muñoz N; Paavonen J; Haupt RM;
Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):287-96. PubMed ID: 21300618
[TBL] [Abstract][Full Text] [Related]
31. Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK.
Cuzick J; Castañón A; Sasieni P
Br J Cancer; 2010 Mar; 102(5):933-9. PubMed ID: 20104226
[TBL] [Abstract][Full Text] [Related]
32. Pre-vaccination distribution of human papillomavirus (HPV) genotypes in women with cervical intraepithelial neoplasia grade 3 (CIN 3) lesions in Slovenia.
Kovanda A; Juvan U; Sterbenc A; Kocjan BJ; Seme K; Jancar N; Vrtacnik-Bokal E; Poljak M
Acta Dermatovenerol Alp Pannonica Adriat; 2009 Jun; 18(2):47-52. PubMed ID: 19588057
[TBL] [Abstract][Full Text] [Related]
33. Distribution of Human Papillomavirus (HPV) Genotypes in HIV-Negative and HIV-Positive Women with Cervical Intraepithelial Lesions in the Eastern Cape Province, South Africa.
Taku O; Mbulawa ZZA; Phohlo K; Garcia-Jardon M; Businge CB; Williamson AL
Viruses; 2021 Feb; 13(2):. PubMed ID: 33670231
[TBL] [Abstract][Full Text] [Related]
34. Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States.
Hariri S; Johnson ML; Bennett NM; Bauer HM; Park IU; Schafer S; Niccolai LM; Unger ER; Markowitz LE;
Cancer; 2015 Aug; 121(16):2775-81. PubMed ID: 26098295
[TBL] [Abstract][Full Text] [Related]
35. Different detectability of high-risk HPV in smears from incident and prevalent high-grade squamous intraepithelial lesions of the cervix.
Schneider A; Zahm DM; Greinke C; Kirchmayr R; Nindl I
Gynecol Oncol; 1997 Jun; 65(3):399-404. PubMed ID: 9190964
[TBL] [Abstract][Full Text] [Related]
36. Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New Zealand.
Kang YJ; Lewis H; Smith MA; Simonella L; Neal H; Bromhead C; Canfell K
BMC Infect Dis; 2015 Aug; 15():365. PubMed ID: 26297490
[TBL] [Abstract][Full Text] [Related]
37. [Investigation on the prevalence of high risk human papillomavirus and cervical cancer among adult women, in Shenzhen].
DU H; Wu RF; Tang HR; Wu LN; Zhang LJ; Liu ZH; Li J; Li RZ; Wang GP; Zhou YQ; Wang C; Weng LM
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):799-802. PubMed ID: 22967332
[TBL] [Abstract][Full Text] [Related]
38. Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.
Cleveland AA; Gargano JW; Park IU; Griffin MR; Niccolai LM; Powell M; Bennett NM; Saadeh K; Pemmaraju M; Higgins K; Ehlers S; Scahill M; Johnson Jones ML; Querec T; Markowitz LE; Unger ER;
Int J Cancer; 2020 Feb; 146(3):810-818. PubMed ID: 30980692
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia.
Quek SC; Lim BK; Domingo E; Soon R; Park JS; Vu TN; Tay EH; Le QT; Kim YT; Vu BQ; Cao NT; Limson G; Pham VT; Molijn A; Ramakrishnan G; Chen J
Int J Gynecol Cancer; 2013 Jan; 23(1):148-56. PubMed ID: 23221730
[TBL] [Abstract][Full Text] [Related]
40. Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program.
Baldur-Felskov B; Dehlendorff C; Junge J; Munk C; Kjaer SK
Cancer Causes Control; 2014 Jul; 25(7):915-22. PubMed ID: 24797870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]